Switch to:
More From Other Websites
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3... Dec 11 2014
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3... Dec 11 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Dec 11 2014
Nektar/AstraZeneca's Moventig Gets EU Approval for OIC Dec 10 2014
MOVENTIG® Approved In The European Union For Opioid-Induced Constipation Dec 09 2014
MOVENTIG® Approved In The European Union For Opioid-Induced Constipation Dec 09 2014
AstraZeneca, Nektar constipation drug wins European approval Dec 09 2014
AstraZeneca, Nektar constipation drug wins European approval Dec 09 2014
Biotech: When and Where to Sell Dec 03 2014
Baxter Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII... Dec 01 2014
Nektar Therapeutics (NKTR): Strong Industry, Solid Earnings Estimate Revisions Dec 01 2014
Will Nektar Therapeutics (NKTR) Continue to Surge Higher? Nov 26 2014
FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation Nov 24 2014
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a... Nov 20 2014
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a... Nov 20 2014
Nektar Therapeutics (NKTR): An Off-the-Radar Potential Winner Nov 17 2014
NEKTAR THERAPEUTICS Financials Nov 14 2014
10-Q for Nektar Therapeutics Nov 10 2014
Nektar Therapeutics Beats on Q3 Earnings and Revenues Nov 10 2014
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report Nov 07 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK